Cargando…

Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer

BACKGROUND: The aim of this study was to construct a predictive signature integrating tumour-mutation- and copy-number-variation-associated features using machine learning to precisely predict early relapse and survival in patients with resected stage I–II pancreatic ductal adenocarcinoma. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Lei, Yuan, Xiaodong, Zhao, Liangchao, Han, Quanli, Yan, Huan, Yuan, Jing, Guan, Shasha, Xu, Xiaofeng, Dai, Guanghai, Wang, Junqing, Shi, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191445/ https://www.ncbi.nlm.nih.gov/pubmed/37196196 http://dx.doi.org/10.1093/bjsopen/zrad031

Ejemplares similares

Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection
por: Guan, Shasha, et al.
Publicado: (2019)

S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study
por: Shi, Yan, et al.
Publicado: (2022)

Survival of patients with advanced pancreatic cancer after iodine(125) seeds implantation brachytherapy: A meta-analysis
por: Han, Quanli, et al.
Publicado: (2017)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Nab-paclitaxel plus S-1 in advanced pancreatic adenocarcinoma (NPSPAC): a single arm, single center, phase II trial
por: Shi, Yan, et al.
Publicado: (2017)

A robust gene signature for the prediction of early relapse in stage I–III colon cancer
por: Dai, Weixing, et al.
Publicado: (2018)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
por: Brown, J E, et al.
Publicado: (2000)

Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro
por: Lv, Yao, et al.
Publicado: (2017)

Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
por: Han, Peng, et al.
Publicado: (2021)

Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer
por: Cao, Da-Long, et al.
Publicado: (2020)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2023)

An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma
por: Hong, Yu, et al.
Publicado: (2015)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma
por: Chen, Yang, et al.
Publicado: (2017)

Correlation Between Baseline Serum Tumor Markers and Clinical Characteristic Factors in Patients with Advanced Pancreatic Cancer
por: Deng, Guo-chao, et al.
Publicado: (2020)

Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas
por: Klotz, Barbara, et al.
Publicado: (2019)

Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
por: Zhang, Weiwei, et al.
Publicado: (2022)

A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer
por: Li, Na, et al.
Publicado: (2020)

Early Stage Relapsing Polychondritis Diagnosed by Nasal Septum Biopsy
por: Kobayashi, Takaaki, et al.
Publicado: (2015)

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy
por: Ren, Kang, et al.
Publicado: (2022)

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
por: Guler, Gulfem D., et al.
Publicado: (2020)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
por: Zhou, Qian, et al.
Publicado: (2023)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

Pancreatic Perfusion CT in Early Stage of Severe Acute Pancreatitis
por: Tsuji, Yoshihisa, et al.
Publicado: (2012)

miRNA Signature in Early-stage Mycosis Fungoides
por: SØRENSEN, Sissel T., et al.
Publicado: (2022)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma
por: Boevers, Emily, et al.
Publicado: (2017)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma
por: Woof, Victoria G., et al.
Publicado: (2022)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies
por: de Jong, Greta, et al.
Publicado: (2019)

Early Diagnosis of Pancreatic Cancer: The Key for Survival
por: Gheorghe, Gina, et al.
Publicado: (2020)

Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer
por: Min, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g9qrtf2te2hgenr4cgh2ot09vo